Axillary reverse lymphatic mapping in breast cancer surgery: A comprehensive review

Expert Review of Anticancer Therapy

Volumn 14, Issue 7, 2014, Pages 771-781

  Seyednejad, Nazgol ^a   Kuusk, Urve ^a   Wiseman, Sam M ^a,b,c  

^a ST PAUL S HOSPITAL   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ARM procedure; Axillary lymph node dissection; Axillary reverse lymphatic mapping; Biopsy; Breast cancer; Lymphedema; sentinel lymph node; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; AXILLARY LYMPH NODE; AXILLARY REVERSE LYMPHATIC MAPPING; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHEDEMA; PATIENT SAFETY; REVIEW; RISK REDUCTION; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT INDICATION; ADVERSE EFFECTS; ARM; AXILLA; BREAST NEOPLASMS; FEMALE; LYMPH NODE; PATHOLOGY; PROCEDURES;

ARM; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHEDEMA; SENTINEL LYMPH NODE BIOPSY;

EID: 84903130605     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2014.896209     Document Type: Review

References (33)

1. Noguchi M. Axillary reverse mapping for breast cancer. Breast Cancer Res Treat 2010;119(3):529-35
2. Noguchi M. Axillary reverse mapping for preventing lymphedema in axillary lymph node dissection and/or sentinel lymph node biopsy. Breast Cancer 2010;17(3):155-7
3. Deng H, Chen L, Jia W, et al. Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. J Cancer Res Clin Oncol 2011;137(12): 1869-74
4. Iwase H, Yamamato Y, Kawasoe T,Ibusuki M. Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surg Today 2009;39:374-80
5. Klimberg VS. A new concept toward the prevention of lymphedema: Axillary reverse mapping. J Surg Oncol 2008;97(7):563-4 (Pubitemid 351794142
6. Bedrosian I, Babiera GV, Mittendorf EA,et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 2010;116(11):2543-8
7. Khan SA, Lurie RH. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: Defining the limits of the concept. J Clin Oncol 2009;27(33): 5494-6
8. Thompson M, Korourian S,Henry-Tillman R, et al. Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 2007;14(6):1890-5 (Pubitemid 46870948
9. Boneti C, Korourian S, Diaz Z, et al. Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg 2009;198(4): 482-7
10. Casabona F, Bogliolo S, Valenzano M,et al. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol 2009; 16(9):2459-63
11. Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol 2010;101(3):217-21
12. Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: Mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 2008;206(5):1038-42
13. Noguchi M, Noguchi M, Nakano Y, et al. Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol 2012;105(3):229-34
14. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. J Am Med Assoc 2011;305(6):569-75
15. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252(3): 426-32
16. Nos C, Kaugmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 2008;15(9):2550-5
17. Ikeda K, Ogawa Y, Komatsu H, et al. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients. World J Surg Oncol 2012;10:233
18. Tausch C, Baege A, Dietrich D, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?. Eur J Surg Oncol 2013;39(8):880-6
19. Ponzone R, Mininanni P, Cassina E,Sismondi P. Axillary reverse mapping in breast cancer: Can we spare what we find?. Ann Surg Oncol 2008;15(1):390-1
20. Ponzone R, Cont NT, Maggiorotto F. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol 2009;27(33):5547-51
21. Klompenhouwer EG, Gobardhan PD,Beek MA, et al. The clinical relevance of axillary reverse mapping (ARM): Study protocol for a randomized controlled trial. Trials 2013;14:111
22. Rubio IT, Cebrecos I, Peg V, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer. J Surg Oncol 2012;106(1): 89-93
23. Han JW, Seo YJ, Choi JE, et al. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer 2012;15(1): 91-7
24. Pavlista D, Eliska O. Relationship between the lymphatic drainage of the breast and the upper extremity: A postmortem study. Ann Surg Oncol 2012;19(11):3410-15
25. Pavlista D, Eliska O. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla - A lesson from the past - contribution to the concept of axillary reverse mapping. Eur J Surg Oncol 2012;38(5):390-4
26. Casabona F, Bogliolo S, Ferrero S, et al. Axillary reverse mapping in breast cancer: A new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol 2008;15(11): 3318-19
27. Whelan Y, Ackerman I, Chapman JW,et al. MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol ASCO Annual Meeting Proceed (Post-Meeting Edition) 2011;29
28. Fehm T, Helms G, Banys M, Kühn T. Management of the axilla for ipsilateral breast cancer recurrence after previous sentinel lymph node biopsy and breast conserving therapy. Gynecol Surg 2011;8: 13-18
29. Ahmed RL, Prizment A, Lazovich D, et al. Lymphedema and quality of life in breast cancer survivors: The Iowa Women's Health Study. J Clin Oncol 2008;26:5689-96
30. Klompenhouwer EG, Gobardhan PD,Beek MA, et al. The clinical relevance of axillary reverse mapping (ARM): Study protocol for a randomized controlled trial. Trials 2013;14:111
31. Boughey JC, Suma VJ, Mittendorf EA,et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. JAMA 2013; 310(14):1455-61
32. Kuehn Y, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective,multicentre cohort study. Lancet Oncol 2013;2045(13):609-18
33. Gobardhan PD, Wijsman JH, van Dalen T,et al. ARM: Axillary reverse mapping - The need for selection of patients. Eur J Surg Oncol 2012;38(8):657-61.